Antiplatelet therapy: targeting the TxA2 pathway. - Wikidata - wikimedia - TriplyDB

Antiplatelet therapy: targeting the TxA2 pathway.

Antiplatelet therapy: targeting the TxA2 pathway.

http://www.wikidata.org/entity/Q38172461

about

Synthetic polyphosphate inhibits endogenous coagulation and platelet aggregation in vitro Review and Updates in Regenerative and Personalized Medicine, Preclinical Animal Models, and Clinical Care in Cardiovascular Medicine.Antiplatelet and anti-proliferative action of disintegrin from Echis multisquamatis snake venom.Platelet function tests: a comparative review.A Variant in COX-2 Gene Is Associated with Left Main Coronary Artery Disease and Clinical Outcomes of Coronary Artery Bypass Grafting.Effects of pulmonary static inflation with 50% xenon on oxygen impairment during cardiopulmonary bypass for stanford type A acute aortic dissection: A pilot study.Association between thromboxane A2 receptor polymorphisms and asthma risk: A meta-analysis.Glucose Homeostasis and Cardiovascular Alterations in Diabetes.A Central Role for Monocyte-Platelet Interactions in Heart Failure.Predictors of high on-aspirin platelet reactivity in elderly patients with coronary artery disease.Platelet Aggregometry Testing: Molecular Mechanisms, Techniques and Clinical Implications.Antiplatelet pyrazolopyridines derivatives: pharmacological, biochemical and toxicological characterization.

P2860

Q28559769-C63A293E-2150-40D4-B9AB-2EFDA3CFC152 Q30278548-0BAB1937-BF28-4354-A915-848F1D4F584E Q33619942-72763DA3-91A6-4440-A261-2E440F3A807B Q35121464-BB65FDF8-574B-45B1-9A35-A689BB905407 Q37618237-C9144B08-70C3-4AC1-AD1B-381E7FE911CA Q37696861-D26E2AC7-86B5-4A5C-94DF-F10AB979E70E Q38381525-CA854A46-704D-4674-940B-9B05AC2F220A Q38596700-670B3CE7-3090-4E47-A19F-B3BD65B87136 Q38620927-F65E7606-E78B-4F63-B450-7AC3098C7496 Q41405409-ABF959F2-5D75-43B3-8836-BB5D0B95D310 Q41574497-C649C059-228F-4F5C-A973-08F8811C8F28 Q48622988-AFD9BBE3-58CF-43FF-94DC-7856D3CE1135

P2860

Antiplatelet therapy: targeting the TxA2 pathway.

http://www.wikidata.org/entity/Q38172461

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Antiplatelet therapy: targeting the TxA2 pathway.

@en

type

label

Antiplatelet therapy: targeting the TxA2 pathway.

@en

prefLabel

Antiplatelet therapy: targeting the TxA2 pathway.

@en

P1433

Q38172461-D8CF17E3-EED9-47B5-AC1D-E83874CC213F

P1476

Q38172461-0936B19B-4BF8-4B9D-ABCC-F9CB009D71DB

P2093

Q38172461-59A521F0-7B26-47F6-9260-CB6103E26401

Q38172461-9B4A9CE7-3C28-4CD6-A225-8AEB7A66C06B

P2860

Q38172461-002BC6F4-1965-4BD4-932C-B39445593C90

Q38172461-01686B26-EA04-4D34-B353-5E73BBF6DA44

Q38172461-03475457-574A-4ED0-AB60-ED2C82D0B6F9

Q38172461-03CE39A4-30BB-44C5-81EF-C3DF4AC8F51A

Q38172461-0D1AA09B-4C7F-46E6-ABDD-595AB6A02ED7

Q38172461-11D9BC92-F62B-4552-BBA4-106E10E78A26

Q38172461-184C8A85-46C7-463D-BA98-7CA9D2756323

Q38172461-1AFB6308-81C9-47BE-B975-481F9FFE6EF8

Q38172461-1C13A878-E4B0-438B-B563-E486822C936A

Q38172461-1FC5CD29-2933-4088-8393-886CE3B4B347

P2888

Q38172461-E7EF3410-B456-460C-B60F-6C5953FB8A2B

P304

Q38172461-5E5992AD-6118-44EC-9DA1-AFC3FC23AB38

P31

Q38172461-A0003BD5-F1E4-401C-8A9E-9CDDEE5CAE91

P356

Q38172461-8543E7E0-988E-4CFA-9603-A331FADD2B4C

P407

Q38172461-2B9DADB4-5416-4E8C-9752-BB76009249E6

P433

Q38172461-4DA30841-9F10-47A4-9DBA-4D9F905F1AC3

P478

Q38172461-39162B49-D4D5-41A9-BCAE-32F3F32A8E65

P50

Q38172461-701FE813-D96C-4BBE-9295-896913964C28

Q38172461-7D2FD2D9-85F5-4A50-ABD0-C917FD0B8FA0

P577

Q38172461-49F46590-088B-4F87-BB67-ED0E811BC640

P5875

Q38172461-2833389B-F8E2-42E4-B608-FEEB77F7B426

P6179

Q38172461-7824C33C-F349-42A6-993C-14AA28FEBC79

P698

Q38172461-E8A44D76-A329-4684-8AC5-5E50C2BF22AD

P356

S12265-013-9529-1

P1433

Journal of Cardiovascular Translational Research

P1476

Antiplatelet therapy: targeting the TxA2 pathway

@en

P2093

A Zufferey

http://www.w3.org/2001/XMLSchema#string

Y Daali

http://www.w3.org/2001/XMLSchema#string

P2860

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)

Cloning and expression of cDNA for a human thromboxane A2 receptor

COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression

Two thromboxane A2 receptor isoforms in human platelets. Opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to Leu mutation

VAMP8/endobrevin is overexpressed in hyperreactive human platelets: suggested role for platelet microRNA

MicroRNAs in platelet production and activation

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction

Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the DAVID study

Aspirin resistance: position paper of the Working Group on Aspirin Resistance

P2888

s12265-013-9529-1

P304

29-38

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12265-013-9529-1

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-12-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259387290

http://www.w3.org/2001/XMLSchema#string

P6179

1051589333

http://www.w3.org/2001/XMLSchema#string

P698

24353037

http://www.w3.org/2001/XMLSchema#string